William Cunningham to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications William Cunningham has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.211
-
Takada S, Ober AJ, Currier JS, Goldstein NJ, Horwich TB, Mittman BS, Shu SB, Tseng CH, Vijayan T, Wali S, Cunningham WE, Ladapo JA. Reducing cardiovascular risk among people living with HIV: Rationale and design of the INcreasing Statin Prescribing in HIV Behavioral Economics REsearch (INSPIRE) randomized controlled trial. Prog Cardiovasc Dis. 2020 Mar - Apr; 63(2):109-117.
Score: 0.169
-
Gamble-George JC, Longenecker CT, Webel AR, Au DH, Brown AF, Bosworth H, Crothers K, Cunningham WE, Fiscella KA, Hamilton AB, Helfrich CD, Ladapo JA, Luque A, Tobin JN, Wyatt GE. ImPlementation REsearCh to DEvelop Interventions for People Living with HIV (the PRECluDE consortium): Combatting chronic disease comorbidities in HIV populations through implementation research. Prog Cardiovasc Dis. 2020 Mar - Apr; 63(2):79-91.
Score: 0.042